Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to see how well Low Pass Whole Genome Sequencing (LP-WGS) can detect circulating tumor deoxyribonucleic acid (ctDNA) in the blood of participants who have bone or...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
NCT06395103 · B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, and more
NCT06498648 · Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, and more
NCT05647265 · Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT04902443 · Viral Associated Malignancies, Kaposi Sarcoma, and more
Levine Cancer Institute
Charlotte, North Carolina
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions